Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enzon Pharma Inc (ENZN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 13,752
  • Shares Outstanding, K 44,220
  • Annual Sales, $ 8,380 K
  • Annual Income, $ -1,130 K
  • 36-Month Beta 1.25
  • Price/Sales 1.74
  • Price/Cash Flow 0.00
  • Price/Book 1.68
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/09/17
  • Annual Dividend & Yield 0.15 (45.46%)
  • Most Recent Dividend 0.30 on 12/13/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2670 +18.88%
on 11/01/17
0.3350 -5.25%
on 11/24/17
+0.0254 (+8.70%)
since 10/24/17
3-Month
0.0300 +958.00%
on 10/19/17
0.4000 -20.65%
on 08/29/17
-0.0686 (-17.77%)
since 08/24/17
52-Week
0.0300 +958.00%
on 10/19/17
0.4990 -36.39%
on 11/30/16
-0.0956 (-23.15%)
since 11/23/16

Most Recent Stories

More News
Enzon Pharmaceuticals Partnering Deals and Alliances 2010 to 2017

SummaryThis report provides all the information you require to better understand Enzon Pharmaceuticals and its partnering interests and activities since 2010.

ENZN : 0.3174 (+2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Key Turning Points

2nd Resistance Point 0.3363
1st Resistance Point 0.3237
Last Price 0.3174
1st Support Level 0.3047
2nd Support Level 0.2983

See More

52-Week High 0.4990
Fibonacci 61.8% 0.3198
Last Price 0.3174
Fibonacci 50% 0.2645
Fibonacci 38.2% 0.2092
52-Week Low 0.0300

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart